Clinical Trial Update: CLaret Embolic Protection ANd TAVI - Trial [NA]

View source ↗

Summary

Clinical trial update on the CLaret Embolic Protection and TAVI trial sponsored by the University of Leipzig, focusing on cerebral perfusion defect frequency an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Claret Embolic Protection Device

Snippet

Sponsor: University of Leipzig | Conditions: Frequency of Cerebral Perfusion Defects After TAVI, Size of Cerebral Perfusion Defects After TAVI | NA | Status: UNKNOWN